Exalenz Bioscience Launches H. Pylori Breath Test

Exalenz Biosciences, a Jersey City, N.J.-based GI and liver condition diagnostic medical device development company, has announced the global launch of its BreathID Hp.

Advertisement

The BreathID Hp is designed as a non-invasive, quick and accurate test for the detection of H. pylori.

More Articles on Gastroenterology:
4 GI Devices Receive FDA 510(k) Clearance in May & June
FDA Will Not Require IND for Fecal Microbiota Transplant
Endoscopy Device Market to be Worth $4.3B by 2017

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • From new gastroenterology practices and specialty partnerships to workforce research, here are five gastroenterologists in recent Becker’s headlines:  1. Washington,…

  • Private equity and corporate buyers have turned gastroenterology into one of the most consolidated specialties in outpatient care.  Here are…

Advertisement

Comments are closed.